C
CERO//CIK 0001870404
CERO THERAPEUTICS HOLDINGS, INC.
Market Data
$0.05−$0.02 (−30.56%)
CERO · Last trade
Prev Close
$0.07
Range (30d)
$0.04 – $0.08
Recent Filings
- 8-K12.2 MBCERO THERAPEUTICS HOLDINGS, INC.Jan 7, 4:37 PM ET·0001213900-26-002187
- 8-K259.6 KBCERO THERAPEUTICS HOLDINGS, INC.Dec 19, 4:49 PM ET·0001213900-25-123912
- S-120.2 MBCERO THERAPEUTICS HOLDINGS, INC.Dec 5, 5:12 PM ET·0001213900-25-118817
- 8-K956.4 KBCERO THERAPEUTICS HOLDINGS, INC.Dec 2, 8:30 AM ET·0001213900-25-116971
- 10-Q9.4 MBCERO THERAPEUTICS HOLDINGS, INC.Nov 19, 4:10 PM ET·0001213900-25-112619
- 8-K264.2 KBCERO THERAPEUTICS HOLDINGS, INC.Oct 29, 7:27 PM ET·0001213900-25-103661
- 8-K628.5 KBCERO THERAPEUTICS HOLDINGS, INC.Oct 16, 4:17 PM ET·0001213900-25-099560
- 8-K1.3 MBCERO THERAPEUTICS HOLDINGS, INC.Oct 14, 9:11 AM ET·0001213900-25-098421
- 8-K19.6 MBCERO THERAPEUTICS HOLDINGS, INC.Sep 22, 4:10 PM ET·0001213900-25-090107
- 8-K263.9 KBCERO THERAPEUTICS HOLDINGS, INC.Sep 5, 8:32 AM ET·0001213900-25-084737
Insiders
10- ATWOOD BRIAN GDirector
- Byrnes MichaelDirector
- Carter Charles RossChief Financial Officer
- Corey DanielDirector, Chief Technical Officer
- Ehrlich Christopher BDirector, Chairman and CEO
- Fisher Douglas CarlPresident
- Geffken Daniel E.Chief Financial Officer
- Kosacz BarbaraDirector
- KUCHARCHUK ANDREW ALBERTChief Financial Officer
- LAPORTE KATHLEENDirector
Tickers
Addresses
business
201 HASKINS WAY SUITE 230
SOUTH SAN FRANCISCO, CA, 94080
mailing
201 HASKINS WAY SUITE 230
SOUTH SAN FRANCISCO, CA, 94080
Former Names
- CERO THERAPEUTICS HOLDINGS, INC.2026-01-07
- PHOENIX BIOTECH ACQUISITION CORP.2024-02-14